Gilead Sciences Announces Third Quarter 2019 Financial Results

Go back to Gilead Sciences Announces Third Quarter 2019 Financial Results

Gilead Sciences (GILD) Tops Q3 EPS by 1c

October 24, 2019 4:03 PM EDT

Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $1.75, $0.01 better than the analyst estimate of $1.74. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.61 billion.

GUIDANCE:

Gilead Sciences sees FY2019 revenue of $21.8-22.1 billion, versus the consensus of... More